Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,138.80
(
-0.49%
)
US TECH 100
26,346.80
(
-0.84%
)
Dow Jones
49,141.93
(
-0.34%
)
Brent Oil
104.41
(
2.25%
)
Bitcoin
76,290.24
(
-1.40%
)
News Focus
News Focus
Post# of 80490
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

investor maven

Send PM Follow Ignore
Followers 5
Posts 487
Boards Moderated 0
Alias Born 10/15/2013

investor maven

Re: Whosetosay post# 49783

Tuesday, 06/03/2014 10:56:06 AM

Tuesday, June 03, 2014 10:56:06 AM

Post# of 80490
Except in the case of Ponatinib and AP26113 it's "many months" of life extension, with actually good quality of life for most patients. There are many other cnancer drugs that would fit this MD's comments (are you sure your quote is related to ARAID's drugs?) that offer only a few weeks life extention with poor quality.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today